Ginkgo Bioworks
 Ginkgo Bioworks  (Biotechnology, Big pharma)    | |
|---|---|
 | |
| Formation | 2009 |
| Headquarters | Boston, Massachusetts, USA |
| Interests | synthetic biology |
| Membership | • Tom Knight • Jason Kelly • Reshma Shetty • Barry Canton • Austin Che • Christina Agapakis • Ryan Morhard |
| "Designs, engineers, develops, tests and licenses organisms” | |
Ginkgo Bioworks was founded in 2009 by a group of MIT scientists focused on “engineering biology” for a variety of purposes.
Officially, Ginkgo Bioworks “designs, engineers, develops, tests and licenses organisms”. The company refers to their work as “biology by design”[1], stating that they “program cells to make everything from food to materials to therapeutics.”
Ginkgo Bioworks work in a sector of biotechnology called synthetic biology (synbio), which is the intersection of biology and technology. The ultimate goal of this field is to replace factories with biological foundries that can produce everything we need directly (with a little genetic tweaking) from nature.[2]
The company collaborates with DARPA[3][4], and in November 2020 the U.S. government granted Ginkgo a $1.1 billion loan for “COVID-19 testing and the production of raw materials for therapies that may help address future pandemics”.[5]
Further Reading
- Who is Ginkgo Bioworks and How Do They Fit In the Bio-Security, Transhumanist Agenda? by Derek Broze
References
- ↑ https://www.ginkgobioworks.com/
- ↑ https://www.nanalyze.com/2020/10/ginkgo-bioworks-industrial-synbio/
- ↑ https://www.prnewswire.com/news-releases/ginkgo-bioworks-and-transcriptic-selected-by-darpa-to-leverage-robotic-cloud-lab-and-foundry-automation-to-accelerate-biological-design-with-9-5-m-award-300628716.html
- ↑ https://www.prnewswire.com/news-releases/ginkgo-bioworks-azitra-florida-international-university-and-latham-biopharm-group-awarded-15m-by-darpa-to-develop-skin-microbiome-based-mosquito-repellent-301195161.html
- ↑ https://www.reuters.com/article/us-health-coronavirus-loan-ginkgo/u-s-loans-1-1-billion-to-ginkgo-bioworks-for-pandemic-effort-idUSKBN2851TA
